Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SKYE | SEER | CRDF | ||
| Company | Skye Bioscience Inc | Seer Inc Cl A | Cardiff Oncology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.31 | 2.30 | 2.55 | ||
| High | 4.49 | 2.43 | 2.59 | ||
| Low | 4.16 | 2.30 | 2.47 | ||
| Last | 4.17 | 2.38 | 2.50 | ||
| Change | -0.11 | +0.09 | -0.03 | ||
| % Change | -2.57% | +3.93% | -1.19% | ||
| Volume | 100,850 | 186,438 | 459,915 | ||
| 20-Day Average Volume | 166,723 | 292,384 | 1,097,074 | ||
| Previous Close | 4.28 | 2.29 | 2.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.13 | 2.15 | 3.10 | ||
| 20-Day Raw Stochastic | 1.71% | 82.31% | 2.09% | ||
| 20-Day Relative Strength | 41.20% | 65.34% | 43.42% | ||
| Weighted Alpha | -24.85 | +42.41 | -5.15 | ||
| Today's Opinion | 88% Sell | 100% Buy | 32% Sell | ||
| Previous Opinion | 88% Sell | 100% Buy | 24% Sell | ||
| Last Month's Opinion | 64% Sell | 32% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -23.05% since 11/14/24 | -1.45% since 11/14/24 | -11.80% since 11/14/24 | ||
| Low | 4.21 on 11/21/24 | 2.22 on 11/18/24 | 2.46 on 11/21/24 | ||
| High | 5.63 on 11/15/24 | 2.43 on 11/21/24 | 2.88 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -9.98% since 10/21/24 | +24.87% since 10/21/24 | -9.57% since 10/21/24 | ||
| Low | 4.21 on 11/21/24 | 1.82 on 10/24/24 | 2.46 on 11/21/24 | ||
| High | 5.96 on 11/08/24 | 2.50 on 11/14/24 | 4.38 on 11/07/24 | ||
| 3-Month | |||||
| %Chg | -22.77% since 08/21/24 | +44.55% since 08/21/24 | +7.51% since 08/21/24 | ||
| Low | 2.95 on 09/20/24 | 1.59 on 09/11/24 | 2.09 on 09/06/24 | ||
| High | 7.47 on 08/27/24 | 2.50 on 11/14/24 | 4.38 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | -64.70% since 05/21/24 | +15.78% since 05/21/24 | -29.24% since 05/21/24 | ||
| Low | 2.95 on 09/20/24 | 1.56 on 07/09/24 | 2.01 on 08/05/24 | ||
| High | 12.60 on 05/23/24 | 2.50 on 11/14/24 | 4.38 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 129,847 | 135,034 | 129,369 | ||
| Shares Outstanding, K | 30,338 | 58,967 | 51,134 | ||
| Annual Sales | 0 | 16,660,000 | 490,000 | ||
| Annual Net Income | -37,640,000 | -86,280,000 | -41,440,000 | ||
| Last Quarter Sales | 0 | 4,030,000 | 170,000 | ||
| Last Quarter Net Income | -3,900,000 | -21,330,000 | -11,860,000 | ||
| 60-Month Beta | 1.74 | 1.45 | 1.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 11/07/24 | -0.34 on 11/06/24 | -0.25 on 11/07/24 | ||
| Latest Earnings Date | 11/07/24 | 11/06/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||